Protirelin

普罗瑞林

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameProtirelin
Drug Alias NameProtirelinum普罗替瑞林protirelinaAntepanThyrel TRH +[7] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionThyrotropin releasing hormone receptor ligands
TargetsThyrotropin releasing hormone receptor
Therapy Area/IndicationsHypothyroidism
Global Approved IndicationsHypothyroidism
Approved Indications in ChinaHypothyroidism
Original Approved Country/TerritoryUnited States
Original Approved Date1976/11/05
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Livzon Pharmaceutical Co Ltd
Inactive CompaniesAbbott Laboratories
Active IndicationsHypothyroidism
Inactive IndicationsN/A

Other Information

ATC CodeV04CJ02
Related LinksWikipediaDrugBankKEGG